Search

Search bills, members, committees and pages...

ROYAL BIOLOGICS

4 federal lobbying filings, 2025 to 2026.

ROYAL BIOLOGICS is a client on 4 federal lobbying filings, 2025 to 2026, reporting $110K across them. OrthoBiologics and life science company Based in New Jersey.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
THE MCMANUS GROUP4$110K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20261$20K
20253$90K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid4

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 2561Skin Substitute Access and Payment Reform Act of 20253
H.R. 5768Skin Substitute Access and Payment Reform Act2
H.R. 6852Advanced Wound Care and Regenerative Medicine Access and Reform Act2

Lobbyists

Named on the filings.

LobbyistClientsFilings
JOHN MCMANUS14
ALEX WHALEN13

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ROYAL BIOLOGICSTHE MCMANUS GROUP2026 first_quarter$20KApr 20, 2026
ROYAL BIOLOGICSTHE MCMANUS GROUP2025 fourth_quarter$50KJan 20, 2026
ROYAL BIOLOGICSTHE MCMANUS GROUP2025 third_quarter$40KOct 20, 2025
ROYAL BIOLOGICSTHE MCMANUS GROUP2025 third_quarterAug 4, 2025